LabCorp 2015 Annual Report Download - page 70

Index
4 Nominating and Corporate Governance

 - Mr. King serves as Chairman of the Board, President, and Chief Executive Officer. Refer to the biography above in the Board of Directors
section.
Mr. Eisenberg has served as Executive Vice President, Chief Financial Officer since June 2014. Mr. Eisenberg received his Bachelors of
Arts degree from Tulane University in 1982 and his Master of Business Administration from Georgia State University in 1988. From 2002 until he joined the
Company, he served as the Executive Vice President, Finance and Administration and Chief Financial Officer at The Timken Company, a $4.3 billion
leading global manufacturer of highly engineered bearings and alloy steels and related products and services. Previously, he served as President and Chief
Operating Officer of United Dominion Industries, now a subsidiary of SPX Corporation after working in several roles in finance, including Executive Vice
President and Chief Financial Officer of United Dominion. Mr. Eisenberg served on the boards of directors of Family Dollar Stores Inc. until July 2015, where
he chaired the Audit Committee, and Alpha Natural Resources Inc. until May 2015, where he was the lead independent director and chaired the Nominating
and Corporate Governance Committee.
 Mr. Boyle has served as Executive Vice President and Chief Executive Officer of LabCorp Diagnostics since February 19, 2015. Prior
to that, he served as Executive Vice President, Chief Operating Officer since October 2009. Prior to October 2009, Mr. Boyle was Senior Vice President,
Managed Care since May 2006. In December of 2008, Mr. Boyle also assumed operating responsibility for the Company’s Occupational Testing/Employer
Group Services in his then current role of Senior Vice President of Managed Care/OTS. Mr. Boyle previously held the position of Vice President of Managed
Care from August 2004 to May 2006. Prior to that Mr. Boyle was the Director of Litigation and Assistant General Counsel from 1999 to 2004. Prior to joining
the Company in 1999, Mr. Boyle was engaged in the private practice of law for more than 15 years, specializing in litigation. He currently serves as a member
of the Seton Hall University Board of Regents.
Ms. Keller serves as the Chief Executive Officer of Covance Drug Development, a position she has held since August 2015. Prior to
being named as the Chief Executive Officer in August 2015, Ms. Keller had served as the Executive Vice President, Covance and Group President, R&D
Laboratories since November 2010, which includes Central Laboratory Services, Nonclinical Safety Assessment, Analytical Services, and Discovery and
Translational Services. Ms. Keller holds a Bachelor of Science in chemistry and Bachelor of Business Administration in management & accounting from
Nazareth College and a Masters in Business Administration from the University of Wisconsin-Madison. She is a board member for BioCrossroads, an
organization that promotes Indiana’s life science industry, and serves on the advisory board of the Indiana University Kelley School of Business Life
Sciences Program. A member of the American Association of Pharmaceutical Society and the Society of Toxicology, Ms. Keller was named one of
FierceBiotech’s 10 Top Women in Biotech 2012.
  Mr. Berberian has served as Senior Vice President, Chief Information Officer since February 2014. Prior to that, he served as Chief
Information Officer at IDEXX Laboratories, a global leader in diagnostics and IT solutions for animal health and food and water quality, from May 2007 to
January 2014. Mr. Berberian served as Chief Information Officer and President of Kellstrom Aerospace Defense, a fully integrated supply chain firm, from
January 2000 to April 2007. He also served as Chief Information Officer of Interim Healthcare from September 1997 to January 2000.
   Mr. Dodson has served as Senior Vice President, Chief Accounting Officer since June 2005. He also has served as the Principal
Accounting Officer since December 2014. Mr. Dodson, who has been a Certified Public Accountant for 32 years, joined the Company in August 1997 as Vice
President and Corporate Controller and became Senior Vice President in June 2001. Prior to joining the Company in 1997, Mr. Dodson was a senior manager
in the audit and consulting practice of KPMG, LLP., where he worked for 17 years in that firm's Greensboro, NC and Brussels, Belgium offices.
Mr. Eberts has served as Senior Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer since January 1, 2009.
Prior to that time he served as Senior Vice President, General Counsel since August 2004. Prior to joining the Company, he was Vice President, Secretary, and
General Counsel of Stepan Company. Before joining Stepan Company, he was Assistant General Counsel for Cardinal Health, Inc. from 1998 to 2001 and
Associate General Counsel for Allegiance Healthcare Corporation (Allegiance Healthcare Corporation was purchased by Cardinal Health in 1998). Prior to
that time, he was Chief Counsel of the Biotech North America division of Baxter International Inc.
 Mrs. Uthgenannt has served as Chief Human Resources Officer since March 2015. Prior to that she served as Senior Vice President
Human Resources for Covance since she joined Covance in November 2010. Prior to joining Covance, Ms. Uthgenannt held numerous leadership positions
at Johnson & Johnson, in both medical devices and pharmaceutical businesses since 2000. In her last role as Vice President, Human Resources for the
Comprehensive Care sector, she served as a key advisor
70